FOLH1 and prostate cancer: In prostate cancer xenograft models, darolutamide-mediated increase of PSMA expression facilitated tumor uptake of PSMA-TTC, and darolutamide also impaired PSMA-TTC-mediated induction of DNA damage repair genes (80).